Efficacy and Safety of Encaleret in Autosomal Dominant Hypocalcemia Type 1

  • N Engl J Med. 2023 Sep 28;389(13):1245-1247. doi: 10.1056/NEJMc2302708.
Rachel I Gafni  1 ,  Iris R Hartley  1 ,  Kelly L Roszko  1 ,  Edward F Nemeth  2 ,  Karen A Pozo  3 ,  Ed Lombardi  4 ,  Ananth V Sridhar  4 ,  Mary S Roberts  4 ,  Jonathan C Fox  4 ,  Michael T Collins  5
Affiliations
  • 1. National Institutes of Health, Bethesda, MD [email protected].
  • 2. MetisMedica, Toronto, ON, Canada.
  • 3. National Institutes of Health, Bethesda, MD.
  • 4. BridgeBio Pharma, San Francisco, CA.
  • 5. National Institutes of Health, Bethesda, MD [email protected].
PMID: 37754292 DOI: 10.1056/NEJMc2302708
Products